TOWARD PHARMACOLOGICAL MODIFICATION OF JOINT DAMAGE IN OSTEOARTHRITIS

被引:21
作者
BRANDT, KD
机构
关键词
D O I
10.7326/0003-4819-122-11-199506010-00011
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:874 / 875
页数:2
相关论文
共 20 条
[1]  
BURKHARDT D, 1987, Seminars in Arthritis and Rheumatism, V17, P3
[2]   TRANS-REPRESSOR ACTIVITY OF NUCLEAR GLYCOSAMINOGLYCANS ON FOS AND JUN/AP-1 ONCOPROTEIN-MEDIATED TRANSCRIPTION [J].
BUSCH, SJ ;
MARTIN, GA ;
BARNHART, RL ;
MANO, M ;
CARDIN, AD ;
JACKSON, RL .
JOURNAL OF CELL BIOLOGY, 1992, 116 (01) :31-42
[3]  
BUUCKLANDWRIGHT JC, IN PRESS NEW HORIZON
[4]  
DIPASQUALE G, 1993, JOINT CARTILAGE DEGR, P475
[5]  
DOUGADOS M, 1992, J RHEUMATOL, V19, P378
[6]  
GOLUB LM, 1993, Patent No. 5258371
[7]  
GREENWALD RA, 1994, INHIBITION MATRIX ME, V732, P181
[8]   A CRITICAL-REVIEW OF INTERVENTIONS TO IMPROVE COMPLIANCE WITH PRESCRIBED MEDICATIONS [J].
HAYNES, RB ;
WANG, E ;
GOMES, MD .
PATIENT EDUCATION AND COUNSELING, 1987, 10 (02) :155-166
[9]  
HOWELL DS, 1991, J RHEUMATOL, V18, P138
[10]  
HOWELL DS, IN PRESS NEW HORIZON